Renaissance Technologies’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$452K Buy
149,200
+19,800
+15% +$60K ﹤0.01% 2884
2025
Q1
$551K Sell
129,400
-12,900
-9% -$55K ﹤0.01% 2702
2024
Q4
$751K Sell
142,300
-194,440
-58% -$1.03M ﹤0.01% 2639
2024
Q3
$616K Buy
336,740
+186,340
+124% +$341K ﹤0.01% 2688
2024
Q2
$313K Buy
150,400
+65,800
+78% +$137K ﹤0.01% 2894
2024
Q1
$339K Sell
84,600
-28,700
-25% -$115K ﹤0.01% 3038
2023
Q4
$212K Buy
113,300
+53,200
+89% +$99.5K ﹤0.01% 3114
2023
Q3
$100K Sell
60,100
-23,500
-28% -$39.1K ﹤0.01% 3247
2023
Q2
$200K Buy
83,600
+24,694
+42% +$59.1K ﹤0.01% 3305
2023
Q1
$184K Sell
58,906
-8,094
-12% -$25.3K ﹤0.01% 3305
2022
Q4
$180K Sell
67,000
-12,200
-15% -$32.8K ﹤0.01% 3454
2022
Q3
$234K Buy
79,200
+25,000
+46% +$73.9K ﹤0.01% 3319
2022
Q2
$159K Buy
54,200
+16,600
+44% +$48.7K ﹤0.01% 3732
2022
Q1
$192K Sell
37,600
-27,200
-42% -$139K ﹤0.01% 3662
2021
Q4
$437K Sell
64,800
-51,100
-44% -$345K ﹤0.01% 3140
2021
Q3
$802K Buy
115,900
+64,473
+125% +$446K ﹤0.01% 2669
2021
Q2
$501K Buy
51,427
+20,027
+64% +$195K ﹤0.01% 2964
2021
Q1
$494K Buy
31,400
+14,290
+84% +$225K ﹤0.01% 2909
2020
Q4
$414K Sell
17,110
-20,676
-55% -$500K ﹤0.01% 2904
2020
Q3
$636K Buy
37,786
+7,800
+26% +$131K ﹤0.01% 2735
2020
Q2
$879K Buy
29,986
+4,100
+16% +$120K ﹤0.01% 2605
2020
Q1
$595K Buy
25,886
+4,783
+23% +$110K ﹤0.01% 2672
2019
Q4
$346K Buy
21,103
+1,917
+10% +$31.4K ﹤0.01% 3032
2019
Q3
$200K Buy
19,186
+1,613
+9% +$16.8K ﹤0.01% 3148
2019
Q2
$292K Buy
17,573
+6,179
+54% +$103K ﹤0.01% 3181
2019
Q1
$229K Buy
11,394
+3,429
+43% +$68.9K ﹤0.01% 3171
2018
Q4
$723K Sell
7,965
-445
-5% -$40.4K ﹤0.01% 2719
2018
Q3
$656K Buy
8,410
+748
+10% +$58.3K ﹤0.01% 2765
2018
Q2
$751K Buy
7,662
+1,759
+30% +$172K ﹤0.01% 2700
2018
Q1
$590K Buy
5,903
+865
+17% +$86.5K ﹤0.01% 2856
2017
Q4
$383K Buy
5,038
+740
+17% +$56.3K ﹤0.01% 2950
2017
Q3
$344K Buy
4,298
+1,193
+38% +$95.5K ﹤0.01% 2875
2017
Q2
$189K Buy
3,105
+1,792
+136% +$109K ﹤0.01% 3004
2017
Q1
$92K Buy
1,313
+550
+72% +$38.5K ﹤0.01% 3090
2016
Q4
$58K Buy
+763
New +$58K ﹤0.01% 3155